Berkshire Hathaway Inc. (LON:0R37)

Verve Therapeutics Revenue

Berkshire Hathaway had revenue of $92.52B USD in the quarter ending June 30, 2025, a decrease of -1.22%. This brings the company's revenue in the last twelve months to $370.15B, up 0.01% year-over-year. In the year 2024, Berkshire Hathaway had annual revenue of $371.43B with 1.91% growth.

• Revenue (ttm): $370.15B
• Revenue Growth: +0.01%
• P/S Ratio: 2.76
• Revenue / Employee: $943.30K
• Employees: 392,400
• Market Cap: 745.15B

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	371.43B	6.95B	1.91%
Dec 31, 2023	364.48B	62.46B	20.68%
Dec 31, 2022	302.02B	25.84B	9.35%
Dec 31, 2021	276.19B	30.61B	12.46%
Dec 31, 2020	245.58B	-9.04B	-3.55%